Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Supriya Lifescience Legal & Regulatory

Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.

Source

BSE filing, NSE: SUPRIYA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Supriya Lifescience Ltd: key numbers

Share price
₹838.20
Market cap
₹6,746 Cr
Revenue (annual)
₹827.9 Cr
Net profit (annual)
₹209.1 Cr
P/E (TTM)
34.0×Sector 47.2×
Promoter holding
68.30%+0.00% QoQ
FII holding
6.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Supriya Lifescience Ltd

All →

Other legal & regulatory announcements

All →